NUSCALE POWER Corp
Business
NuScale Power Corp develops and commercializes small modular reactor (SMR) technology aimed at delivering safe, scalable, cost‑effective, carbon‑free power. Its main products include the NuScale Power Module™ (NPM) and associated NSSS equipment, together with services such as licensing support, testing, training, fuel supply and program management across the plant lifecycle. The company operates in a single business segment focused on SMR equipment and services and leverages strategic partners and supply‑chain collaborations for manufacturing and EPC delivery. NuScale targets domestic and international customers including governments, utilities, state‑owned enterprises and industrial off‑takers through direct sales, licensing and developer partnerships like ENTRA1.
Summary from filing dated 2025-03-03
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenue (2025 - $23,921; 2024 - $4,225; 2023 - $16,897 from related party) | 31 | 37 | 23 | 12 | 3 | |
| Cost of sales | −20 | −5 | −19 | −7 | −2 | |
| Gross margin | 11 | 32 | 4 | 4 | 1 | |
| Research and development expenses | 46 | 47 | 156 | 128 | 94 | |
| General and administrative expenses | 610 | 76 | 65 | 55 | 39 | |
| Other expenses (2025 - $0; 2024 - $767; 2023 - $32,875 from related party) | 46 | 48 | 58 | 52 | 42 | |
| Loss from operations | −690 | −139 | −276 | −230 | −174 | |
| Sponsored cost share | 149,000 | 7 | 61 | 73 | 74 | |
| Change in fair value of warrant liabilities | 0 | −223 | 24 | 12 | 0 | |
| Investment income | 25 | 8 | 11 | 4 | — | |
| Loss before income taxes | −664 | −346 | −180 | −142 | −102 | |
| Foreign income taxes | 342,000 | 2 | 0 | 0 | — | |
| Net loss | −664 | −348 | −180 | −142 | −102 | |
| Net loss attributable to noncontrolling interests | −309 | −212 | −122 | −85 | 0 | |
| Net Loss Attributable to Class A Common Stockholders | −356 | −137 | −58 | −26 | −102 | |
| Basic (usd per share) | −2.17 | −1.47 | −0.8 | −0.51 | 0 | |
| Diluted (usd per share) | −2.17 | −1.47 | −0.8 | −0.51 | 0 | |
| Basic (shares) | 164 | 93 | 73 | 51 | 0 | |
| Diluted (shares) | 164 | 93 | 73 | 51 | 0 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 836 | 402 | 120 | 218 | 77 | |
| Short-term investments | 418 | 40 | 0 | 50 | 0 | |
| Restricted cash | 5 | 5 | 5 | 0 | — | |
| Prepaid expenses | 5 | 3 | 19 | 6 | 4 | |
| Accounts and other receivables, net (2025 - $5,452; 2024 - $3,655 from related party) | 8 | 21 | 10 | 11 | — | |
| Total current assets | 1,273 | 471 | 155 | 284 | 86 | |
| Property, plant and equipment, net | 2 | 2 | 4 | 5 | 5 | |
| In-process research and development | 17 | 17 | 17 | 17 | 17 | |
| Intangible assets, net | 527,000 | 704,000 | 882,000 | 1 | 1 | |
| Goodwill | 8 | 8 | 8 | 8 | 8 | |
| Long-lead material work in process | 64 | 43 | 36 | 0 | — | |
| Investments | 33 | 0 | — | — | — | |
| Other assets | 16 | 2 | 4 | 7 | 4 | |
| Total Assets | 1,413 | 545 | 225 | 349 | 121 | |
| Accounts payable and accrued expenses | 287 | 48 | 45 | 28 | 22 | |
| Accrued compensation | 8 | 7 | 9 | 9 | 11 | |
| Long-lead material liability | 0 | 32 | 32 | 0 | — | |
| Other accrued liabilities | 648,000 | 1 | 2 | 2 | 1 | |
| Deferred revenue | 613,000 | 762,000 | 0 | — | — | |
| Total current liabilities | 296 | 90 | 87 | 39 | 48 | |
| Deferred revenue | 335,000 | 181,000 | 898,000 | 856,000 | 1 | |
| Noncurrent liabilities | 3 | 2 | 1 | 3 | 3 | |
| Total Liabilities | 299 | 92 | 96 | 72 | 53 | |
| Additional paid-in capital | 1,902 | 996 | 334 | 297 | 0 | |
| Accumulated deficit | −733 | −377 | −240 | −182 | −782 | |
| Total Stockholders' Equity Excluding Noncontrolling Interests | 1,169 | 619 | 93 | 115 | 66 | |
| Noncontrolling interests | −55 | −166 | 36 | 162 | 0 | |
| Total Stockholders' Equity | 1,114 | 453 | 129 | 277 | 66 | |
| Total Liabilities and Stockholders' Equity | 1,413 | 545 | 225 | 349 | 121 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation | 1 | 2 | 2 | 3 | 2 | |
| Amortization of intangibles | 177,000 | 177,000 | 177,000 | 177,000 | 177,000 | |
| Equity-based compensation expense | 19 | 14 | 16 | 9 | 6 | |
| Provision for credit losses | 0 | 1 | 0 | 0 | — | |
| Loss on disposal of property, plant and equipment | 0 | −122,000 | 0 | 0 | — | |
| Impairment of intangible asset | 0 | 71,000 | 797,000 | 0 | 0 | |
| Prepaid expenses and other assets | −16 | 16 | −10 | −2 | −2 | |
| Accounts and other receivables (2025 - $(1,797); 2024 - $(1,013) and 2023 - $(1,134) from related party) | 10 | −12 | 1 | — | — | |
| Long-lead material work in process | −17 | −7 | −36 | 0 | 0 | |
| Accounts payable and accrued expenses (2025 - $0; 2024 - $(4,080) and 2023 - $(3,614) from related party) | 238 | 6 | 18 | 3 | 6 | |
| Long-lead material liability | −32 | 4,000 | 32 | — | — | |
| Lease liability | 895,000 | −2 | −4 | −2 | −2 | |
| Deferred revenue | 5,000 | 45,000 | 42,000 | −559,000 | 1 | |
| Accrued compensation | 950,000 | −1 | −323,000 | −2 | 5 | |
| Net Cash Used in Operating Activities | −460 | −109 | −183 | −149 | −99 | |
| Proceeds from sale of short-term investments | 164 | 25 | 50 | — | — | |
| Proceeds from sale of investments | 92 | 0 | 0 | — | — | |
| Purchase of short-term investments | −542 | −65 | 0 | −50 | 0 | |
| Purchase of investments | −125 | 0 | 0 | — | — | |
| Insurance proceeds for property, plant and equipment | 0 | 195,000 | 0 | 0 | — | |
| Purchases of property, plant and equipment | −508,000 | −44,000 | −2 | −2 | −2 | |
| Net Cash (Used) Provided by Investing Activities | −411 | −40 | 48 | −52 | −2 | |
| Proceeds from the issuance of common stock, net of issuance fees | 1,300 | 205 | 10 | 0 | 0 | |
| Proceeds from exercise of warrants | 0 | 205 | 0 | 22 | — | |
| Proceeds from exercise of common stock options | 6 | 22 | 6 | 6 | — | |
| Foreign income tax withholding to NCI interests | −416,000 | −3 | 0 | 0 | — | |
| Net Cash Provided by Financing Activities | 1,306 | 430 | 16 | 368 | 173 | |
| Net Change in Cash, Cash Equivalents and Restricted Cash | 435 | 281 | −119 | 167 | 72 | |
| Warrants converted into equity | 0 | 229 | 0 | 6 | 0 | |
| Cash paid for income taxes | 2 | 3 | 0 | 0 | — |